Solventum Corp. (SOLV) - Total Assets
Based on the latest financial reports, Solventum Corp. (SOLV) holds total assets worth $14.24 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Solventum Corp. - Total Assets Trend (2021–2025)
This chart illustrates how Solventum Corp.'s total assets have evolved over time, based on quarterly financial data. Also see market value of Solventum Corp. for the company's overall valuation and market capitalisation.
Solventum Corp. - Asset Composition Analysis
Current Asset Composition (December 2025)
Solventum Corp.'s total assets of $14.24 Billion consist of 27.0% current assets and 73.0% non-current assets. Review SOLV current and long-term liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 6.1% |
| Accounts Receivable | $1.03 Billion | 7.2% |
| Inventory | $1.07 Billion | 7.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.59 Billion | 18.1% |
| Goodwill | $5.70 Billion | 39.9% |
Asset Composition Trend (2021–2025)
This chart illustrates how Solventum Corp.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Solventum Corp. stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Solventum Corp.'s current assets represent 27.0% of total assets in 2025, an increase from 15.6% in 2021.
- Cash Position: Cash and equivalents constituted 6.1% of total assets in 2025, up from 0.7% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 57.0% of total assets, a decrease from 73.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 39.9% of total assets.
Solventum Corp. Competitors by Total Assets
Key competitors of Solventum Corp. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$5.82 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Embecta Corp
NASDAQ:EMBC
|
USA | $1.27 Billion |
Solventum Corp. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.02 | 1.22 | 1.70 |
| Quick Ratio | 0.74 | 0.86 | 1.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $78.00 Million | $588.00 Million | $920.00 Million |
Solventum Corp. - Advanced Valuation Insights
This section examines the relationship between Solventum Corp.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.02 |
| Latest Market Cap to Assets Ratio | 1.00 |
| Asset Growth Rate (YoY) | -1.1% |
| Total Assets | $14.29 Billion |
| Market Capitalization | $14.32 Billion USD |
Valuation Analysis
Near Book Valuation: The market values Solventum Corp.'s assets close to their book value (1.00x), suggesting investors view the company's assets at approximately fair value.
Slight Asset Contraction: Solventum Corp.'s assets decreased by 1.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Solventum Corp. (2021–2025)
The table below shows the annual total assets of Solventum Corp. from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $14.29 Billion | -1.13% |
| 2024-12-31 | $14.46 Billion | +3.69% |
| 2023-12-31 | $13.94 Billion | +2.57% |
| 2022-12-31 | $13.59 Billion | -3.42% |
| 2021-12-31 | $14.07 Billion | -- |
About Solventum Corp.
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressing… Read more